You are here: Industry Insights > coronavirus

News List

India to make 300 million Sputnik V vaccines expresspharma
December 21, 2020
India will produce about 300 million doses of Russia’s Sputnik V coronavirus vaccines next year, a Russian official was quoted as saying, nearly three times the previously known number as deals have been signed with more manufacturers.
Chlorhexidine mouthwash can kill novel coronavirus: Study expresspharma
December 18, 2020
Reportedly, chlorhexidine digluconate mouth rinses in 0.2% concentration kill more than 99.9 per cent of SARS CoV 2 virus in minimal contact time of 30 seconds.
New variant of coronavirus identified in the UK pharmatimes
December 16, 2020
Health officials say they have identified a new strain of coronavirus in the UK, as a soaring number of cases has pushed several areas in the South East into into Tier 3 lockdown.
Pharmacovigilance during a pandemic expresspharma
December 10, 2020
As coronavirus has become the new reality for every health worker and life science company to fight in the front, it is time to relook the approach being taken by the industry towards pharmacovigilance.
CR UK makes further cuts in COVID's wake pharmatimes
December 09, 2020
Cancer Research UK has announced further catastrophic cuts in the wake of the coronavirus pandemic, slashing £45 million from its research budget, leaving dozens of potential life-saving projects and hundreds of world-class scientists unfunded.
COVID-19 vaccine will not be made mandatory: Joe Biden expresspharma
December 07, 2020
Biden said he is willing to get inoculated in public to assuage any concerns about the vaccines’ efficacy and safety.
WHO says would be ‘highly speculative’ to say COVID did not emerge in China expresspharma
November 30, 2020
China is pushing a narrative via state media that the virus existed abroad before it was discovered in the central city of Wuhan.
CollPlant Announces Antiviral Agent Program for Potential Treatment of COVID-19 Patients americanpharmaceuticalreview
November 20, 2020
CollPlant announced its development program of an antiviral agent for potential treatment of COVID-19 patients. In-vitro early results of CollPlant's formulations showed significant inhibition of avian coronavirus infectivity.
Pre-existing coronavirus antibodies could help protect children against new pandemic strain worldpharmanews
November 10, 2020
Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection ...
MHRA starts rolling review of AZ’s coronavirus vaccine pharmatimes
November 06, 2020
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has started an accelerated or rolling review of AstraZeneca’s coronavirus vaccine candidate, the British pharma giant confirmed on Sunday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page